Moderna, Inc.

The extensive R&D programs supporting incremental expansion of respiratory syncytial virus (RSV) vaccines were on display at the US Centers for Disease Control and Prevention’s Advisory Committee

The Advisory Committee on Immunization Practices’ first meeting under the Trump Administration provided an early public look at concerns that a top FDA official has about vaccine efficacy, safety and

Health and Human Services Secretary Robert F. Kennedy Jr. was open about the highly unusual delay of Novavax ’s COVID-19 vaccine licensure by political officials during a 9 April CBS News interview,

News that US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) director Peter Marks submitted his resignation, effective 5 April, late in the day on 28 March shook the b